Alnylam Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2834 http://www.alnylam.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

BioBoyScout’s Online Biotech Valuation Calculators Help Small Investors See Value in Arrowhead Pharmaceuticals (ARWR) - Aug 15th, 2019 7:00 am
Regeneron Gets FDA Nod for Eylea Injection Prefilled Syringe - Aug 15th, 2019 6:28 am
Biotech Stock Roundup: Amgen's Enbrel Patent Win, AMRN's Setback & More - Aug 14th, 2019 7:21 am
Alnylam to Report New Clinical Results for Givosiran at the 2019 International Congress on Porphyrins and Porphyrias - Aug 14th, 2019 6:00 am
Ironwood Pharmaceuticals and Alnylam Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam’s Givosiran in Acute Hepatic Porphyria (AHP) - Aug 13th, 2019 5:30 am
Alnylam Pharmaceuticals and Ironwood Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam’s Givosiran in Acute Hepatic Porphyria (AHP) - Aug 13th, 2019 5:30 am
Alnylam Adds on Sales, Looks to Pipeline for Further Growth - Aug 12th, 2019 2:13 pm
Edited Transcript of ALNY earnings conference call or presentation 6-Aug-19 12:00pm GMT - Aug 12th, 2019 9:07 am
Alnylam's (ALNY) Q2 Earnings and Revenues Miss Estimates - Aug 7th, 2019 6:13 am
Alnylam Pharmaceuticals Inc (ALNY) Q2 2019 Earnings Call Transcript - Aug 6th, 2019 1:23 pm
Regeneron (REGN) Q2 Earnings Top Estimates, Eylea Sales Solid - Aug 6th, 2019 11:09 am
Alnylam Pharmaceuticals (ALNY) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2019 6:55 am
Alnylam Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Period Activity - Aug 6th, 2019 5:30 am
The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering - Aug 6th, 2019 5:22 am
Alnylam Announces U.S. Food and Drug Administration (FDA) Granted Priority Review of the Givosiran New Drug Application (NDA) for the Treatment of Acute Hepatic Porphyria - Aug 5th, 2019 2:00 pm
bluebird's (BLUE) Loss Wider Than Expected, Revenues Beat - Aug 2nd, 2019 9:12 am
Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q2 - Aug 2nd, 2019 8:28 am
Amgen (AMGN) Catches Eye: Stock Jumps 5.7% - Aug 1st, 2019 7:54 am
Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q2 Earnings Expected to Decline - Jul 30th, 2019 8:38 am
A Look At The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Jul 29th, 2019 8:08 am